Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alex Hoover

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 16, 2023
Continuous Glucose Monitoring Enabled by Fluorescent Nanodiamond Boronic HydrogelJian Zhang, Yongjun Zheng, Jimmy Lee, et al.
Blood Reviews|August 6, 2024
Longitudinal clinical manifestations of Fanconi anemia: A systematized reviewAlex Hoover, Lucie M Turcotte, Rachel Phelan, et al.
Developmental Cell|May 29, 2024
VAMP2 controls murine epidermal differentiation and carcinogenesis by regulation of nucleophagyHan Liu, Peihong Su, Yuanyuan Li, et al.
Cell Reports. Medicine|January 14, 2025
Enabling tumor-specific drug delivery by targeting the Warburg effect of cancerJian Zhang, Tony Pan, Jimmy Lee, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 3, 2025
Enabling Targeted Drug Delivery for Treatment of Ulcerative Colitis with Mucosal-Adhesive Photoreactive HydrogelWen Wu, Jian Zhang, Xiao Qu, et al.
Medrxiv : the Preprint Server for Health Sciences|April 10, 2023
Phase II Study of Myeloablative 8/8- or 7/8-Matched Allotransplantation with Post-Transplant Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil: Marked Reduction in GVHD Risk Without Increased Relapse Risk Compared to Historical Cyclosporine/MethotrexateNajla El Jurdi, Alex Hoover, Daniel O'Leary, et al.
Transplantation and Cellular Therapy|June 13, 2023
Phase II Study of Myeloablative 7-8/8-Matched Allotransplantation with Post-Transplantation Cyclophosphamide, Tacrolimus, and Mycophenolate MofetilNajla El Jurdi, Alex Hoover, Daniel O'Leary, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 16, 2023
Continuous Glucose Monitoring Enabled by Fluorescent Nanodiamond Boronic HydrogelJian Zhang, Yongjun Zheng, Jimmy Lee, et al.
Blood Reviews|August 6, 2024
Longitudinal clinical manifestations of Fanconi anemia: A systematized reviewAlex Hoover, Lucie M Turcotte, Rachel Phelan, et al.
Developmental Cell|May 29, 2024
VAMP2 controls murine epidermal differentiation and carcinogenesis by regulation of nucleophagyHan Liu, Peihong Su, Yuanyuan Li, et al.
Cell Reports. Medicine|January 14, 2025
Enabling tumor-specific drug delivery by targeting the Warburg effect of cancerJian Zhang, Tony Pan, Jimmy Lee, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 3, 2025
Enabling Targeted Drug Delivery for Treatment of Ulcerative Colitis with Mucosal-Adhesive Photoreactive HydrogelWen Wu, Jian Zhang, Xiao Qu, et al.
Medrxiv : the Preprint Server for Health Sciences|April 10, 2023
Phase II Study of Myeloablative 8/8- or 7/8-Matched Allotransplantation with Post-Transplant Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil: Marked Reduction in GVHD Risk Without Increased Relapse Risk Compared to Historical Cyclosporine/MethotrexateNajla El Jurdi, Alex Hoover, Daniel O'Leary, et al.
Transplantation and Cellular Therapy|June 13, 2023
Phase II Study of Myeloablative 7-8/8-Matched Allotransplantation with Post-Transplantation Cyclophosphamide, Tacrolimus, and Mycophenolate MofetilNajla El Jurdi, Alex Hoover, Daniel O'Leary, et al.
Pageof 2